IL62696A - Anti-inflammatory pharmaceutical compositions comprising 4-amino-1beta-d-ribofuranosyl-1h-imidazo(4,5-c)pyridine or a salt thereof - Google Patents

Anti-inflammatory pharmaceutical compositions comprising 4-amino-1beta-d-ribofuranosyl-1h-imidazo(4,5-c)pyridine or a salt thereof

Info

Publication number
IL62696A
IL62696A IL62696A IL6269681A IL62696A IL 62696 A IL62696 A IL 62696A IL 62696 A IL62696 A IL 62696A IL 6269681 A IL6269681 A IL 6269681A IL 62696 A IL62696 A IL 62696A
Authority
IL
Israel
Prior art keywords
1beta
ribofuranosyl
imidazo
pyridine
amino
Prior art date
Application number
IL62696A
Other languages
English (en)
Other versions
IL62696A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL62696A0 publication Critical patent/IL62696A0/xx
Publication of IL62696A publication Critical patent/IL62696A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL62696A 1980-04-23 1981-04-22 Anti-inflammatory pharmaceutical compositions comprising 4-amino-1beta-d-ribofuranosyl-1h-imidazo(4,5-c)pyridine or a salt thereof IL62696A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8013411A GB2074858B (en) 1980-04-23 1980-04-23 Compositions containing 3-deazaaden-osine

Publications (2)

Publication Number Publication Date
IL62696A0 IL62696A0 (en) 1981-06-29
IL62696A true IL62696A (en) 1984-03-30

Family

ID=10512973

Family Applications (1)

Application Number Title Priority Date Filing Date
IL62696A IL62696A (en) 1980-04-23 1981-04-22 Anti-inflammatory pharmaceutical compositions comprising 4-amino-1beta-d-ribofuranosyl-1h-imidazo(4,5-c)pyridine or a salt thereof

Country Status (15)

Country Link
EP (1) EP0038567B1 (xx)
JP (1) JPS56166118A (xx)
AU (1) AU553680B2 (xx)
BE (1) BE888525A (xx)
CA (1) CA1172168A (xx)
CH (1) CH654316A5 (xx)
DE (2) DE3176462D1 (xx)
DK (1) DK179781A (xx)
GB (1) GB2074858B (xx)
IE (2) IE51737B1 (xx)
IL (1) IL62696A (xx)
IT (1) IT1170910B (xx)
NL (1) NL8101987A (xx)
NZ (1) NZ196883A (xx)
ZA (1) ZA812640B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU596637B2 (en) * 1986-08-06 1990-05-10 Sumitomo Chemical Company, Limited Mulching film for repelling insect pests
US4918060A (en) * 1987-09-04 1990-04-17 The Johns Hopkins University Method of treating myasthenia gravis and related diseases
US5137876A (en) * 1990-10-12 1992-08-11 Merck & Co., Inc. Nucleoside antiviral and anti-inflammatory compounds and compositions and methods for using same
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
ES2270614T3 (es) * 1998-09-03 2007-04-01 Kerckhoff-Klinik Gesellschaft Mit Beschrankter Haftung 3-desazaadenosina utilizada en la prevencion de la ateroesclerosis y la vasculopatia de los injertos.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148888A (en) * 1978-03-13 1979-04-10 The United States Of America As Represented By The Department Of Health, Education And Welfare 3-Deazaadenosine as an inhibitor of adenosylhomocysteine hydrolase with antiviral activity
DE2967570D1 (en) * 1978-10-13 1986-03-06 Wellcome Found 3-deazaadenosine and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
IE51737B1 (en) 1987-03-18
GB2074858B (en) 1985-03-20
GB2074858A (en) 1981-11-11
CH654316A5 (de) 1986-02-14
DE3176462D1 (en) 1987-10-29
EP0038567B1 (en) 1987-09-23
DK179781A (da) 1981-10-24
AU553680B2 (en) 1986-07-24
DE3116029A1 (de) 1982-03-18
JPS56166118A (en) 1981-12-21
NL8101987A (nl) 1981-11-16
EP0038567A1 (en) 1981-10-28
JPH0428686B2 (xx) 1992-05-15
IE811594L (en) 1981-10-23
IE810891L (en) 1981-10-23
BE888525A (fr) 1981-10-22
AU6971081A (en) 1981-10-29
ZA812640B (en) 1982-12-29
CA1172168A (en) 1984-08-07
IL62696A0 (en) 1981-06-29
IE51738B1 (en) 1987-03-18
DE3116029C2 (xx) 1991-01-17
NZ196883A (en) 1984-07-31
IT1170910B (it) 1987-06-03
IT8148327A0 (it) 1981-04-22

Similar Documents

Publication Publication Date Title
GB2098865B (en) Topical pharmaceutical compositions
DE3172516D1 (en) Penetrating topical pharmaceutical compositions
PH25637A (en) Dipyridamole-containing pharmaceutical form
ZA824622B (en) Pharmaceutical compositions
DE3370620D1 (en) 1,4-dihydropyridine derivatives
EP0106275A3 (en) 1,4-dihydropyridine derivatives
ZA825397B (en) Pharmaceutical compositions
ZA81136B (en) Pharmaceutical compositions
ZA822856B (en) Pharmaceutical compositions
GB2072504B (en) Pharmaceutical compositions
IL62696A (en) Anti-inflammatory pharmaceutical compositions comprising 4-amino-1beta-d-ribofuranosyl-1h-imidazo(4,5-c)pyridine or a salt thereof
ZA815700B (en) Pharmaceutical compositions
DE3378533D1 (en) 1,4-dihydropyridine derivatives
AU558670B2 (en) Pharmaceutical compositions
DE3378313D1 (en) 1,4-dihydropyridine derivatives
IL65976A0 (en) Pharmaceutical compositions comprising a d-homosteroid
ZA817684B (en) Pharmaceutical compositions
MY8700560A (en) Pharmaceutical compositions
ZW18582A1 (en) Pharmaceutical compositions
GB8305525D0 (en) 1,4-dihydropyridine derivatives
ZA822357B (en) Topical pharmaceutical compositions
IL56239A (en) Pharmaceutical compositions comprising certain 1,3-bis-2-carboxy chromonyloxy-2-hydroxypropane salts
GB2080301B (en) Substituted pyrimidin-2-ones the salts thereof processes for their preparation and pharmaceutical compositions containing them
GB2080300B (en) Substituted pyrimidin-2-ones the salts thereof processes for their preparation and pharmaceutical compositions containing them
GB2108108B (en) Novel 1 4-dihydropyridine derivatives